Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Medical school deans say funding cuts jeopardize research and clinical medicine
Cuts in federal support and unreliable funding streams are creating a hostile work environment for scientists, jeopardizing the future of research efforts and ultimately clinical medicine...
BMJ opinion piece calls for reclassification of psychedelics
The schedule 1 classification of LSD, psilocybin and other psychedelics makes research into their potential therapeutic benefits almost impossible, argues one expert.
Pivotal study showing talimogene laherparepvec showed durable response rates in metastatic melanoma published
Amgen has announced the publication of primary results from the Phase 3 OPTiM study in the Journal of Clinical Oncology (JCO).
Study to determine whether aspirin can improve healing rates of leg ulcers, Australia
Researchers are looking at whether aspirin can improve the healing rates of leg ulcers in older adults.
Regrets? Opting out of clinical trials may prompt more than a few
Women who choose not to participate in a clinical trial may be significantly more likely to later regret that decision than women who choose to participate in the study, according to a team of Penn...
Positive topline results announced from Phase 3 studies with sarilumab in patients with rheumatoid arthritis
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that a Phase 3 study of sarilumab, an investigational, fully-human IL6 receptor antibody, met its co-primary efficacy endpoints of a...
Positive results for LATUDA (lurasidone HCI) in first placebo-controlled trial of patients with major depressive disorder with mixed features
Sunovion Pharmaceuticals Inc. has announced results from the first placebo-controlled study in adults with major depressive disorder (MDD) who presented with a limited number of associated manic...
African Americans prone to display negative perceptions of cancer-related clinical trials
African American patients have a disproportionately high rate of cancer, and yet are less likely than Caucasian patients to participate in oncologic clinical trials that can significantly improve...
ORBERA Intragastric Balloon US pivotal trial results presented
Apollo Endosurgery, Inc., a leader in minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures, has announced the presentation of results from the ORBERA&trade...
New Alzheimer's drug to enter clinical trials
A new drug developed at Lancaster University in the UK that may help to prevent the early stages of Alzheimer's disease is to enter clinical trials.
Study results published suggest Veracyte's Percepta Bronchial Genomic Classifier can reduce unnecessary invasive procedures in lung cancer diagnosis
Veracyte, Inc., a molecular diagnostics company pioneering the field of molecular cytology, has announced online publication in the New England Journal of Medicine of results from two large...
Data presented from two Phase 3 trials demonstrating safety and efficacy of buprenorphine HCl buccal film for the management of chronic pain
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc.
New drug combination could extend life of cystic fibrosis patients
Researchers have discovered that a new combination of two drugs could significantly improve the symptoms of patients with the most common form of cystic fibrosis.
Global financial injection 'needed to transform development of antibiotics'
Economist Jim O'Neill unveils proposals to kick-start development of new antibiotics in an effort to combat drug resistance. The new plan may cost just $16 billion over 10 years.
Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients
Invectys has announced that it has initiated a phase I clinical trial of its immunotherapeutic drug candidate INVAC-1.
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2015
Content Management / Website Design by Tresware